Zobrazeno 1 - 10
of 12
pro vyhledávání: ''
Autor:
Qingxia Fan, Xiaotian Zhang, Bing Hu, Wei Bai, Jianming Xu, Yongqian Shu, Li Xia, Tianshu Liu, Wei Liu, Yueyin Pan, Zhihao Lu, Nong Xu, Lin Shen, Yong Gao, Wei Li, Wenling Wang, Yuxian Bai, Qing Xu
Publikováno v:
Gastric Cancer
Background We compared efficacy and safety of paclitaxel/capecitabine therapy followed by capecitabine for maintenance (PACX) versus cisplatin/capecitabine therapy (XP) in advanced gastric cancer. Methods Multicenter, randomized, phase III trial was
Autor:
Masaki Endoh, Yasuko Fujita, Mitsumasa Osakabe, Makoto Eizuka, Wataru Habano, Takayuki Matsumoto, Hiro-o Yamano, Noriyuki Arakawa, Tamotsu Sugai, Hiromu Suzuki, Eiichiro Yamamoto
Publikováno v:
Gastric Cancer
Background We attempted to identify the molecular profiles of gastric intramucosal neoplasia (IMN; low-grade dysplasia, LGD; high-grade dysplasia, HGD; intramucosal cancer, IMC) by assessing somatic copy number alterations (SCNAs) stratified by micro
Publikováno v:
Gastric Cancer
Gastric Cancer, 20(5), 853. Springer Japan
Gastric cancer, 20(5), 853-860. Springer Japan
Gastric Cancer, 20(5), 853. Springer Japan
Gastric cancer, 20(5), 853-860. Springer Japan
BACKGROUND: Minimally invasive techniques for gastric cancer surgery have recently been introduced in the Netherlands, based on a proctoring program. The aim of this population-based cohort study was to evaluate the short-term oncological outcomes of
Autor:
Hiroshi Suito, Naoyuki Hanari, Masaya Uesato, Akiko Kagaya, Yukiko Ogura, Hisahiro Matsubara, Ryuma Urahama, Yorihiko Muto, Tomohide Tamachi, Mizuho Aikawa, Akira Nakano, Takashi Oide
Publikováno v:
Gastric Cancer
Background and aims EUS-guided FNA biopsy has been widely performed to aid in the diagnosis of submucosal tumors (SMTs). However, in cases of small tumors, the diagnostic yield of EUS-FNA is poor. Therefore, it is necessary to develop a new needle fo
Autor:
Shinichi Sakuramoto, Hitoshi Katai, Mitsuru Sasako, Hiroshi Imamura, Koji Kitada, Masanori Terashima, Atsushi Ochiai, Issei Kurahashi, Wataru Ichikawa, Takeshi Sano
Publikováno v:
Gastric Cancer
Background Exploratory biomarker analysis was conducted to identify factors related to the outcomes of patients with stage II/III gastric cancer using data from the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer, which was a randomized control
Autor:
Na Rae Lee, Mi Seon Kang, Jin Hee Sohn, Yang Seok Chae, Hee Kyung Chang, Joon Mee Kim, Hyunki Kim, Do Youn Park, Kyoung-Mee Kim, So Young Jin, Jae Hyuk Lee, Seung Hee Park, Hwoon-Yong Jung, Eun Sun Jung, Woo Ho Kim, Myeong Cherl Kook, Youn Wha Kim, Young Soo Park, Hoguen Kim, Ji Hye You, Seung Sik Hwang, Sang Yong Seol, Mee Yon Cho
Publikováno v:
Gastric Cancer
Background Discrepancies in the clinicopathologic parameters pre- and post-endoscopic submucosal dissection (ESD) sometimes necessitate additional surgical resection. The aim of this study was to assess such discrepancies in clinicopathologic paramet
Autor:
Daisuke Gomi, Narikazu Boku, Yusuke Tanigawara, Tsunehiro Takahashi, Hirofumi Kawakubo, Hiroya Takeuchi, Kenzo Soejima, Yuko Kitagawa, Kazunari Tateishi, Takashi Ichiyama, Takuro Mizukami, Yasuo Hamamoto, Chiyo K. Imamura, Eisuke Booka
Publikováno v:
Gastric Cancer
Background S-1 is an oral anticancer drug, containing tegafur (a prodrug of 5-fluorouracil, 5-FU), 5-chloro-2,4-dihydroxypyridine, and potassium oxonate. As renal dysfunction is known to increase exposure of 5-FU following S-1 administration, the inc
Autor:
Jian Li, Jinwan Wang, Yi Ba, Weichang Chen, Yunpeng Liu, Leizhen Zheng, Tianshu Liu, Rui-Hua Xu, Dong Ma, Shunchang Jiao, Yongqian Shu, Lin Shen, Yuxian Bai, Shukui Qin, Guanghai Dai, Nanfeng Fan, Jianming Xu
Publikováno v:
Gastric Cancer
Background The V325 study showed that docetaxel, cisplatin, and fluorouracil (DCF) prolonged overall survival (OS) of patients with advanced gastric cancer, but with a high incidence of dose-limiting toxicities. We investigated the efficacy and safet
Autor:
Guanghai Dai, Lin Shen, Shukui Qin, Shiying Yu, Liwei Wang, Lilian Bu, Zhenzhou Yang, Rui-Hua Xu, Jinwan Wang, Yongzhe Piao, Yongqian Shu, Lei Chen, Yunpeng Liu, Hongming Pan, Jianming Xu, Jin Li
Publikováno v:
Gastric Cancer
Background In the AVAGAST study, fluoropyrimidine and cisplatin plus bevacizumab did not significantly improve overall survival (OS) versus fluoropyrimidine and cisplatin plus placebo in patients with advanced gastric cancer. Geographic differences i
Autor:
Hiroshi Okabe, Kazutaka Obama, Masatoshi Akagami, Shigeru Tsunoda, Eiji Tanaka, Yoshiharu Sakai
Publikováno v:
Gastric cancer. 16(2):268-274
Proximal gastrectomy has been applied for selected patients with early upper gastric cancer, because of its potential advantages over total gastrectomy, such as preserving gastric capacity and entailing fewer hormonal and nutritional deficiencies. Es